Entering the infusion therapy market presents both exciting opportunities and formidable challenges. From high upfront drug costs to complex reimbursement rules, new entrants must strike a careful balance to achieve profitability and maintain patient satisfaction.
By: Tiffani Bouchard, CCS Managing JW and JZ Modifiers When Billing Single-Dose Drugs Managing JW and JZ modifiers when billing single-dose drugs can be challenging. As […]
Sometimes, even seasoned healthcare professionals get hung up on the intricacies of the pharmacoeconomics of patient assistance programs. If you’re looking to brush up on the […]
How Hard is it for Infusion Centers to Handle their Own Billing? I get this question a lot, and the answer is really complex. There are […]